CYP2D6 metabolism determines drug use in psychiatric disorders

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 419, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Pharmacogenetics and Drug Therapy in Psychiatry - The Role of the CYP2D6 Polymorphism

By  

Current Pharmaceutical Design, Vol. 13, Iss. 2, 2007-01 ,pp. : 241-250

Bentham Science Publishers

Access to resources Recommend Favorite

Concurrent use of celecoxib and CYP2D6 substrates common

By  

Inpharma, Vol. 1, Iss. 1503, 2005-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Use of CYP2D6 genotyping in practice: tamoxifen dose adjustment

By Walko Christine M   McLeod Howard  

Pharmacogenomics, Vol. 13, Iss. 6, 2012-04 ,pp. : 691-697

Future Medicine

Access to resources Recommend Favorite

Prediction of In Vivo Drug-Drug Interactions from In Vitro Data: Factors Affecting Prototypic Drug-Drug Interactions Involving CYP2C9, CYP2D6 and CYP3A4

By Brown Hayley S.   Galetin Aleksandra   Hallifax David   Houston J. Brian  

Clinical Pharmacokinetics, Vol. 45, Iss. 10, 2006-01 ,pp. : 1035-1050

Adis International

Access to resources Recommend Favorite